| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967235 | Vaccine | 2013 | 7 Pages |
Abstract
⺠New technologies provide hope that an RSV vaccine can finally be achieved. ⺠There are opportunities to facilitate the chance of achieving an RSV vaccine. ⺠There are 4 potential target populations. Each has unique challenges and opportunities. ⺠Clinical trials of vaccines are needed to translate results in the lab to a human vaccine. ⺠Additional disease burden data is needed to appropriately prioritize RSV vaccine research.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
L.J. Anderson, P.R. Dormitzer, D.J. Nokes, R. Rappuoli, A. Roca, B.S. Graham,